Mr Anand Shirur, CMD South Asia and China, Convatec
The year 2014 has been very favorable for Convatec and we have experienced high double digit rate growth. Currently, the market size is expanding. Acceptance of the products have increased with doctors, nurses and people.
In the coming years we are planning to expand our reach by investing in home healthcare and geriatric care. In 2015, we are planning to launch few products like creams and lotions intended for hospital purposes in the market. Next year will be very exciting for the company and we are also planning to increase the number of wound clinics we have established in India.
Our major focus is customer satisfaction and we aim to reach more people spread across tier-II and tier-IV. In order to keep market exciting and doubling Convatec will continue to launch new products in the market.
The new government in India is showing promising progress for the biotech sector and this is a very good news for the industry. The trend is very encouraging for industries and we can see a unique drive in this government.
As an industry body, our expectations from the government include-one-window clearance for companies that wish to set up units in India, simplified tax structure, encourage make in India, and also increase funding to further foster the sector.